An immunotherapy technology for treating cancer and other diseases, jointly developed by Victoria University of Wellington’s Ferrier Research Institute and the Malaghan Institute of Medical Research, has been patented and will be the initial focus of a newly-formed company.
The research has been led by Dr Gavin Painter from Ferrier Research
and Dr Ian Hermans from the Malaghan Institute, and works as a
therapeutic vaccine, activating a patient’s own immune system to
recognise and attack cancer cells.